Physician profile
Myron Bodnar
NPI 1457356032
$436.28
in general payments reported to CMS, 2019-2025
14 companies · $63.97 in 2025
The $63.97 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.23 · 2022: $112 · 2023: $115 · 2024: $119 · 2025: $63.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $279 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $279.33 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $79.17 | 2022-2023 | Durysta |
| Oyster Point Pharma, INC. | $42.21 | 2022-2025 | Ryzumvi, Tyrvaya |
| Bausch & Lomb Americas INC. | $39.47 | 2023-2024 | Miebo, Xiidra, Zenlens |
| Harrow Eye, LLC | $36.93 | 2024-2025 | Vevye |
| Alcon Vision LLC | $35.89 | 2023-2024 | Clareon, Hydrus Microstent |
| Novartis Pharmaceuticals Corporation | $35.50 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $34.61 | 2023 | Cequa |
| Rxsight INC | $28.42 | 2024 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Biotissue Holdings INC. | $24.46 | 2023 | |
| Thea Pharma INC. | $18.38 | 2025 | Iyuzeh |
| Dompe US, INC. | $17.78 | 2024 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $15.05 | 2024 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $14.74 | 2021 | |
| Allergan, INC. | $13.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Myron Bodnar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.